Carrier Screening Market Research Report - Global Forecast till 2030

Carrier Screening Market Research Report, by Product & Service (Services and Products), Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and others), Technology (Polymerase Chain Reaction and Microarrays), End-User (Hospitals, Reference Laboratories, Physician Offices, and Clinics and others) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2030

ID: MRFR/Pharma/7283-HCR | February 2021 | Region: Global | 140 pages         

Carrier Screening Market

The Carrier Screening Market is evaluated to have significant growth of up to 15.94%. It is anticipated that the market value will further reach up to USD 8631.66 million by the studied forecast period 2020-2030

Segmentation

By Product & Service Services and Products
By Type Expanded Carrier Screening Targeted Disease Carrier Screening
By Medical Condition Pulmonary Conditions Hematological Conditions Neurological Conditions others
By Technology Polymerase Chain Reaction Microarrays
By End-User Hospitals Reference Laboratories Physician Offices Clinics and others

Key Players

  • Opko Health (US)
  • Quest Diagnostics Incorporated (US)
  • Eurofins Scientific (Luxembourg)
  • Sema4 (US)
  • Fulgenmt Genetics Inc. (US)
  • Invitae Corporation (US)
  • Laboratory Corporation of America Holdings (US)
  • Illumina Inc.

Drivers

  • Increasing the launch of new carrier screening tests across the world is driving market growth
  • An increasing number of players involved in the development of carrier screening.
Speak to Analyst Request a Free Sample

Carrier Screening Market Overview


The Carrier Screening Market is evaluated to have significant growth of up to 15.94%. It is anticipated that the market value will further reach up to USD 8631.66 million by the studied forecast period 2020-2030. The carrier screening is genetic testing that is used to under the cause of gene disorders. This type of test is mainly done during the pregnancy and provides significant information about the woman's risks for reproduction and chances of a genetic disorder of the child.


The demand for this type of test has increased to prevent any disorders and risks. With the help of expanded carrier screening, it is now easy to detect around 100 disorders from a single sample.  Also, the targeted carrier screening helps in identifying any disease by analyzing the family medical history. Also, medical conditions such as pulmonary and haematological conditions will have the highest growth in the Career Screening Market.


COVID-19 Analysis


The Coronavirus disease caused a huge ruckus in the Career Screening Market. Various incidents like financial disruption, supply, and management, manufacturing units were halted so several months. This led to an increase in the gap in production and demand in the market. Moreover, after the waiver of lockdown, various key players began to improve the market growth with investments, partnerships, acquisitions, etc. Henceforth, the market will observe immense growth in the future years.


Market Dynamics


Market Drivers


The increasing demand for early detection of diseases and development in technology will drive the Career Screening Market Growth. Also, the investment by key players for new technologies will further improve the market growth in the future.


Restraints


The low awareness for new technologies will act as a significant restraint for the Career Screening Market Growth. The unavailability of basic guidelines for carrier screening will further restrict the market growth.


Opportunities


The increasing investments by key players and rapid technological advancements will offer new opportunities for Career Screening Market Growth.


Challenges


The problem regarding the accuracy of data can be a major challenge for the Career Screening Market. Henceforth, this factor can hinder the Career Screening Market.


Cumulative Analysis


The Compound Annual Growth Rate (CAGR) of the Carrier Screening Market is estimated to boost up to 17.40%. It is also evaluated that the Carrier Screening industry Value will further reach up to USD 7.40 Billion by the studied forecast period 2021-2028.


Value Chain Analysis


The improvement in technology and rapid technological development is projected to boost the Carrier Screening Market Trends. Also, the strengthening of the supply chain and rising demand for better healthcare infrastructure will further enhance the value chain of the Carrier Screening industry in the forthcoming years.


Market Segmentations


The Carrier Screening Market Size is segmented into Products and Services, Type, and Medical Condition. Based on type, the Carrier Screening Market is fragmented into Targeted Carrier Screening, Expanded Carrier Screening. The Expanded Carrier Screening is divided into Customized Panel Testing and Predesigned Panel Testing. With the help of expanded carrier screening, it is easy to detect around 100 gene disorders.  Furthermore, the targeted carrier screening helps identify gene disorders by analyzing the family history.


Based on Medical conditions, the Carrier Screening Market is bifurcated into Hematological Conditions, Pulmonary Conditions, Neurological Conditions, and others.  The hematological sub-segment is anticipated to have the largest share in the market. It is mainly due to the increasing cases of sickle disorders in patients. Also, the pulmonary conditions will have the fastest growth in the Carrier Screening Market. The others sub-segments include diseases like trisomy 13, Marfan syndrome, and Down syndrome.


Based on Product and Services, the Carrier Screening Market is again divided into Product and Service. The services sub-segment is evaluated to grow at the fastest rate. Also, the product sub-segment is predicted to observe high growth with the increasing awareness and early diagnosis facility.


Regional Analysis


On the basis of region, the Carrier Screening Market is divided into North America (U.S, Mexico, and Canada), Europe (Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, Australia, South Korea, and Rest of Asia Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).


According to the Carrier Screening Market Forecast by MRFR, it is estimated that North America will hold the largest share in the forthcoming years. The presence of various key players and advanced healthcare solutions are driving the Carrier Screening Market Growth in this region.


Secondly, Europe is predicted to have the second-largest Carrier Screening Market Share in the studied forecast period. With the increasing emphasis on development and research, the market is evaluated to record robust growth. Also, the increasing demand to manufacture personalized machines will influence the Carrier Screening industry positively.


Thirdly, the Asia-Pacific region is predicted to have the fastest growth in the future years. The increasing investments by key players mainly in India and China are playing a crucial role in driving the market. Also, the rising awareness for genetic disorders and the increasing geriatric population are speculated to propel the Carrier Screening Market.


Competitive Landscape


There are various companies present in the Carrier Screening Market. They implement various market strategies to improve their business portfolio across the world. These key players do mergers, partnerships, acquisitions, new ventures, etc. Some of the key players in the Carrier Screening Market are as follows.



  • Opko Health (US)

  • Quest Diagnostics Incorporated (US)

  • Eurofins Scientific (Luxembourg)

  • Sema4 (US)

  • Fulgenmt Genetics Inc. (US)

  • Invitae Corporation (US)

  • Laboratory Corporation of America Holdings (US)

  • Illumina Inc. (US)

  • Natera Inc. (US)

  • BGI Group (China)

  • deCODE Genetics (Iceland)

  • Agilent Technologies (US)

  • Genomic Health (US)

  • Pathway Genomics (US)

  • Bio-Rad Laboratories Inc. (US)

  • Admera Health (US)

  • Abbott Laboratories (US)


Recent Developments



  • GenPath Women's Health which is the subsidiary of OPKO Health in 2017 launched a prenatal screen with a non-invasive procedure called CalriTest. This device will help to identify the abnormal chromosomes.

  • Invitae Corporation in 2018 launched its screening device for comprehensive genetic.


Report Overview


The report overview of Carrier Screening Market Outlook is as follows.



  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development


Report Score and Segmentation


The report score is to give information about the Carrier Screening Market Analysis. It highlights information such as market value, CAGR, opportunities, challenges, etc. The information provided in this report is gathered from various primary and secondary sources.



  • Study Period- 2021-2028

  • Base Year-2021

  • Forecast Period- 2021-2028

  • Historical Period-2017-2020


Segmentation



  • By Type

  • Targeted Carrier Screening

  • Expanded Carrier Screening

  • Customized Panel Testing

  • Predesigned Panel Testing


 



  • By Medical Condition

  • Hematological Conditions

  • Pulmonary Conditions

  • Neurological Conditions

  • Others



  • By Services and Products

  • Products

  • Services



  • By Region

  • North America (U.S, Mexico, and Canada)

  • Europe (Germany, France, Spain, Italy, and Rest of Europe)

  • Asia Pacific (Japan, India, Australia, South Korea, and Rest of Asia Pacific)

  • LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2030: USD 8632.66 Million
  CAGR   15.94% 2030
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product & Service, By Type , By Technology, By End-Use and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Eurofins Scientific (Luxembourg), Invitae Corporation (US), Opko Health (US), Fulgent Genetics Inc (US), Quest Diagnostics Incorporated (US), Sema4 (US), Myriad Genetics (US), Illumina Inc (US), Thermo Fisher Scientific Inc (US), Luminex Corporation (US), Natera Inc (US), Laboratory Corporation of America Holdings (US)
  Key Market Opportunities   The increasing research and development activity and launch of carrier screening products for genetic disease testing is the major factor
  Key Market Drivers

  • Increasing the launch of new carrier screening tests across the world is driving market growth
  • An increasing number of players involved in the development of carrier screening.


  • Speak to Analyst Ask for Customization